Weight ManagementJuly 22, 2026·4 min read
By the CIRRUS Editorial Team — how we write and source this
What happens when you stop GLP-1 drugs — the weight-regain timeline
Trial withdrawal data is specific about how much weight comes back and how fast, once semaglutide or tirzepatide stops.
Withdrawal-phase data from GLP-1 trials is consistent on one point: appetite suppression is not permanent once the drug stops. In semaglutide withdrawal studies, participants regained roughly two-thirds of their lost weight within a year of discontinuation, with most of the regain concentrated in the first several months as GLP-1 receptor activity returns to baseline.
This is the basis for the now-common clinical framing of GLP-1 therapy as chronic disease management rather than a finite course — similar in structure to how hypertension or hyperlipidemia medications are typically continued indefinitely rather than 'completed.' Stopping abruptly without a plan for diet and activity to fill the appetite-regulation gap the drug was providing predicts the fastest regain.
For patients who do stop — due to cost, side effects, or personal choice — the regain curve is gentler when resistance training and protein intake established during the drug course are maintained, since those habits address the muscle-preservation side of the equation independent of appetite suppression.
This article is general health information, not medical advice, and doesn’t replace evaluation by your own physician. Talk to a doctor about anything specific to your own diagnosis or treatment.